News

Thermage is a non-invasive radiofrequency procedure for tightening and contouring skin. Stephen Fanning, chairman of the board, president and CEO of Solta Medical, said: “We are excited about

The initial products will be directed to the ovarian cancer biomarker, HE4, which is FDA-cleared for monitoring the progression or recurrence of epithelial ovarian cancer. Fujirebio also grants

US-based ZymoGenetics has reduced its workforce by approximately 32%, or 161 employees, as part of a corporate restructuring. ZymoGenetics said that it is reorganizing its operations to focus

US-based Medicis and French pharmaceutical company Ipsen have reported that the FDA has approved the biologics license application for Dysport, an acetylcholine release inhibitor and a neuromuscular blocking

ImmunoCellular Therapeutics, a biotechnology company, has received a new US patent relating to the company’s monoclonal antibody therapeutics. The patent covers the use of ImmunoCellular Therapeutics’s (IMUC’s) antibodies

UK-based biopharmaceutical company Oxford BioMedica has reported that, as part of Sanofi-Aventis’s reprioritization of its product portfolio, Oxford BioMedica has regained worldwide rights to TroVax, its therapeutic cancer

Swiss biopharmaceutical company Basilea Pharmaceutica has received approval from the Dutch Medicines Evaluation Board for Toctino, a new once-daily oral treatment for adults with severe chronic hand eczema

Milestone Scientific, a developer of advanced injection technologies, has granted China National Medicines Corporation, doing business as Sinopharm, exclusive distribution and marketing rights of the STA Single Tooth

Lipoxen, a biopharmaceutical company, and Cambridge Biostability, or CBL, a developer of temperature-stable vaccines and biopharmaceuticals, have achieved positive preclinical results for the delivery of an enhanced influenza